膀胱癌发病率和死亡率的趋势：是成功还是令人失望？ - Suppr

Suppr

超能文献

Trends in Bladder Cancer Incidence and Mortality: Success or Disappointment?

作者信息

Babjuk Marko

机构信息

Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University in Praha, Czech Republic.

出版信息

Eur Urol. 2017 Jan;71(1):109-110. doi: 10.1016/j.eururo.2016.06.040. Epub 2016 Jul 11.

DOI:10.1016/j.eururo.2016.06.040

PMID:27417034

Abstract

摘要

相似文献

Trends in Bladder Cancer Incidence and Mortality: Success or Disappointment?膀胱癌发病率和死亡率的趋势：是成功还是令人失望？

Eur Urol. 2017 Jan;71(1):109-110. doi: 10.1016/j.eururo.2016.06.040. Epub 2016 Jul 11.

International variations in bladder cancer incidence and mortality.膀胱癌发病率和死亡率的国际差异。

Eur Urol. 2014 Jul;66(1):59-73. doi: 10.1016/j.eururo.2013.10.001. Epub 2013 Oct 16.

Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control.探讨膀胱癌发病率、死亡率和生存率的相反趋势：对研究和癌症控制的启示。

Intern Med J. 2010 May;40(5):357-62. doi: 10.1111/j.1445-5994.2009.01980.x.

[Incidence and mortality of bladder cancer in China, 2014].[2014年中国膀胱癌的发病率和死亡率]

Zhonghua Zhong Liu Za Zhi. 2018 Sep 23;40(9):647-652. doi: 10.3760/cma.j.issn.0253-3766.2018.09.002.

Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.1981 - 2014年挪威膀胱尿路上皮癌的发病率与生存率

BMC Cancer. 2016 Oct 13;16(1):799. doi: 10.1186/s12885-016-2832-x.

[Incidence of bladder cancer in France: trends from 1980 to 2000].[法国膀胱癌发病率：1980年至2000年的趋势]

Prog Urol. 2003 Sep;13(4):602-7.

Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.北欧国家 1964-2003 年间诊断为肾或膀胱癌患者的生存趋势，随访至 2006 年底。

Acta Oncol. 2010 Jun;49(5):655-64. doi: 10.3109/02841860903575299.

Trends in the incidence of bladder cancer in Nova Scotia: a twenty-year perspective.新斯科舍省膀胱癌发病率趋势：二十年视角

Can J Urol. 2003 Jun;10(3):1880-4.

[Trends in urologic neoplasm mortality and incidence (prostate, bladder, and kidney). Soria, 1950-1988].[1950 - 1988年泌尿系统肿瘤（前列腺、膀胱和肾脏）的死亡率和发病率趋势。索里亚]

Arch Esp Urol. 1989 Jul-Aug;42(6):532-8.

The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection.膀胱癌的全球流行病学：发病率和死亡率趋势的联合回归分析及预测。

Sci Rep. 2018 Jan 18;8(1):1129. doi: 10.1038/s41598-018-19199-z.

引用本文的文献

EIF2S1 in Urinary Extracellular Vesicles as a Novel Diagnostic Marker for Bladder Cancer.尿细胞外囊泡中的真核翻译起始因子2亚基1作为膀胱癌的新型诊断标志物

Cancer Med. 2025 May;14(10):e70964. doi: 10.1002/cam4.70964.

Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer.人类尿液微生物组的失调可能可以区分膀胱癌患者。

Int J Mol Sci. 2024 Sep 21;25(18):10159. doi: 10.3390/ijms251810159.

Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer.唾液酸酶NEU3促进膀胱癌的侵袭性。

Biomedicines. 2024 Jan 16;12(1):192. doi: 10.3390/biomedicines12010192.

Using the Multidimensional Health Locus of Control Scale Form C to Investigate Health Beliefs About Bladder Cancer Prevention and Treatment Among Male Patients: Cross-Sectional Study.使用多维健康控制点量表C型调查男性膀胱癌患者对预防和治疗的健康信念：横断面研究

JMIR Form Res. 2023 Aug 16;7:e43345. doi: 10.2196/43345.

EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer.尿细胞外囊泡上的 EphA2 作为膀胱癌诊断的新型生物标志物及其对膀胱癌侵袭性的影响。

Br J Cancer. 2022 Oct;127(7):1312-1323. doi: 10.1038/s41416-022-01860-0. Epub 2022 Jul 6.

Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.当代健康筛查在膀胱癌诊断中的效用

Diagnostics (Basel). 2022 Apr 21;12(5):1040. doi: 10.3390/diagnostics12051040.

A long noncoding RNA GTF2IRD2P1 suppresses cell proliferation in bladder cancer by inhibiting the Wnt/β‑catenin signaling pathway.长非编码 RNA GTF2IRD2P1 通过抑制 Wnt/β-连环蛋白信号通路抑制膀胱癌中的细胞增殖。

PeerJ. 2022 Apr 11;10:e13220. doi: 10.7717/peerj.13220. eCollection 2022.

Profiling the Bladder Microbiota in Patients With Bladder Cancer.分析膀胱癌患者的膀胱微生物群。

Front Microbiol. 2022 Feb 7;12:718776. doi: 10.3389/fmicb.2021.718776. eCollection 2021.

High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging.紧密连接蛋白 1 高表达可作为膀胱癌分级和分期的预测性生物标志物。

Sci Rep. 2022 Jan 27;12(1):1496. doi: 10.1038/s41598-022-05631-y.

Effect of Traditional Chinese Medicine Combined with Bladder Perfusion with Hydroxycamptothecin on Color Ultrasound and Clinical Efficacy in Patients with Bladder Cancer Surgery.中药联合羟基喜树碱膀胱灌注对膀胱癌手术患者彩色超声及临床疗效的影响

Evid Based Complement Alternat Med. 2021 Nov 9;2021:7178414. doi: 10.1155/2021/7178414. eCollection 2021.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验